SG43955A1 - Delayed release microtablet of 13-phenylpropiophenone derivatives - Google Patents

Delayed release microtablet of 13-phenylpropiophenone derivatives

Info

Publication number
SG43955A1
SG43955A1 SG1996007053A SG1996007053A SG43955A1 SG 43955 A1 SG43955 A1 SG 43955A1 SG 1996007053 A SG1996007053 A SG 1996007053A SG 1996007053 A SG1996007053 A SG 1996007053A SG 43955 A1 SG43955 A1 SG 43955A1
Authority
SG
Singapore
Prior art keywords
pct
active ingredient
weight
release
tablet
Prior art date
Application number
SG1996007053A
Other languages
English (en)
Inventor
Helmut Fricke
Herbert Mueller-Peltzer
Karl Kolter
Volker Buehler
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6484646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG43955(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of SG43955A1 publication Critical patent/SG43955A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
SG1996007053A 1993-04-03 1994-03-24 Delayed release microtablet of 13-phenylpropiophenone derivatives SG43955A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4310963A DE4310963C2 (de) 1993-04-03 1993-04-03 Retardmikrotablette von beta-Phenylpropiophenonderivaten

Publications (1)

Publication Number Publication Date
SG43955A1 true SG43955A1 (en) 1997-11-14

Family

ID=6484646

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007053A SG43955A1 (en) 1993-04-03 1994-03-24 Delayed release microtablet of 13-phenylpropiophenone derivatives

Country Status (28)

Country Link
US (1) US5681588A (cs)
EP (1) EP0691843B1 (cs)
JP (1) JP3625825B2 (cs)
KR (1) KR100315618B1 (cs)
CN (1) CN1092957C (cs)
AT (1) ATE148988T1 (cs)
AU (1) AU678227B2 (cs)
BR (2) BR9406036A (cs)
CA (1) CA2158166C (cs)
CZ (1) CZ284869B6 (cs)
DE (2) DE4310963C2 (cs)
DK (1) DK0691843T3 (cs)
ES (1) ES2098930T3 (cs)
FI (1) FI114610B (cs)
GR (1) GR3023339T3 (cs)
HR (1) HRP940198B1 (cs)
HU (1) HU221590B (cs)
IL (2) IL109097A0 (cs)
NO (1) NO306848B1 (cs)
NZ (1) NZ263565A (cs)
PL (1) PL175219B1 (cs)
RU (1) RU2157191C2 (cs)
SG (1) SG43955A1 (cs)
SI (1) SI9420027A (cs)
TW (1) TW266159B (cs)
UA (1) UA40616C2 (cs)
WO (1) WO1994022434A1 (cs)
ZA (1) ZA942293B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
US20050226923A1 (en) * 2004-04-07 2005-10-13 Gassert Chad M Venlafaxine compositions in the form of microtablets
CA2469339A1 (en) * 2004-06-07 2005-12-07 Bernard Charles Sherman Sustained release propafenone hydrochloride capsules
CA2469327A1 (en) * 2004-06-07 2005-12-07 Bernard Charles Sherman Propafenone hydrochloride capsules containing microtablets
DE102006006532B4 (de) 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
WO2007103557A2 (en) 2006-03-09 2007-09-13 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
US20090035370A1 (en) * 2007-08-02 2009-02-05 Drugtech Corporation Dosage form and method of use
WO2010043950A2 (en) 2008-10-15 2010-04-22 Aizant Drug Research Solutions Private Limited Propafenone extended release composition
CN103908443A (zh) * 2013-11-25 2014-07-09 力品药业（厦门）有限公司 一种盐酸普罗帕酮缓释胶囊及其制备方法
CN107441051B (zh) * 2016-05-30 2022-09-16 北京科信必成医药科技发展有限公司 一种盐酸普罗帕酮微片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951821A (en) * 1972-07-14 1976-04-20 The Dow Chemical Company Disintegrating agent for tablets
DE3210061A1 (de) * 1982-03-19 1983-09-22 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von propafenon
DE3422619A1 (de) * 1984-06-19 1985-12-19 Basf Ag, 6700 Ludwigshafen Zylindrische mikrotabletten
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
DE3725273A1 (de) * 1987-07-30 1989-02-09 Basf Ag Verfahren zur synthese von enantiomeren des propafenons sowie diese enthaltende therapeutische mittel
DE3809764A1 (de) * 1988-03-23 1989-10-05 Knoll Ag Mischung aus alginaten und polyacrylaten und deren verwendung
US4954347A (en) * 1988-05-03 1990-09-04 Basf K & F Corp. Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
DE3911069A1 (de) * 1989-04-06 1990-10-11 Knoll Ag Einkristalle von ss-phenylpropiophenonen
DE59005781D1 (de) * 1990-07-02 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit.
DE4021678C2 (de) * 1990-07-07 1994-07-07 Merz & Co Gmbh & Co Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen
IT1250483B (it) * 1990-08-30 1995-04-07 Eurand Int Sistema di ritardo a matrice multipla

Also Published As

Publication number Publication date
PL175219B1 (pl) 1998-11-30
EP0691843B1 (de) 1997-02-19
AU6429594A (en) 1994-10-24
PL310966A1 (en) 1996-01-22
DE59401833D1 (de) 1997-03-27
WO1994022434A1 (de) 1994-10-13
GR3023339T3 (en) 1997-08-29
CZ284869B6 (cs) 1999-03-17
CZ246595A3 (en) 1996-02-14
KR100315618B1 (ko) 2002-02-28
CA2158166C (en) 2003-10-21
AU678227B2 (en) 1997-05-22
CN1120312A (zh) 1996-04-10
DE4310963A1 (de) 1994-10-06
FI114610B (fi) 2004-11-30
ES2098930T3 (es) 1997-05-01
ATE148988T1 (de) 1997-03-15
FI954686L (fi) 1995-10-02
HUT73248A (en) 1996-07-29
NO953910L (no) 1995-10-02
NO306848B1 (no) 2000-01-03
CA2158166A1 (en) 1994-10-13
IL109097A0 (en) 1994-06-24
NZ263565A (en) 1996-08-27
BR9406036A (pt) 1995-12-12
DE4310963C2 (de) 1997-06-05
HU221590B (hu) 2002-11-28
KR960701630A (ko) 1996-03-28
JPH08508010A (ja) 1996-08-27
HRP940198B1 (en) 1997-12-31
TW266159B (cs) 1995-12-21
RU2157191C2 (ru) 2000-10-10
UA40616C2 (uk) 2001-08-15
IL109097A (en) 1998-09-24
NO953910D0 (no) 1995-10-02
HRP940198A2 (en) 1996-10-31
EP0691843A1 (de) 1996-01-17
CN1092957C (zh) 2002-10-23
SI9420027A (en) 1996-08-31
BR1100303A (pt) 2002-04-02
FI954686A0 (fi) 1995-10-02
ZA942293B (en) 1995-10-02
US5681588A (en) 1997-10-28
JP3625825B2 (ja) 2005-03-02
HU9502879D0 (en) 1995-11-28
DK0691843T3 (da) 1997-04-28

Similar Documents

Publication Publication Date Title
TW266159B (cs)
AU7407387A (en) Controlled release dihydrocodeine composition
IL106693A (en) Controlled sustained release tablets containing bupropion hydrochloride
HK95590A (en) Controlled release naproxen and naproxen sodium tablets
HU9501922D0 (en) Extended release, film-coated tablet of astemizole and pseudoephedrine
GB2196848B (en) Controlled release hydromorphone composition
KR870002832A (ko) 제약 조성물
GR3030106T3 (en) Controlled release morphine preparation.
AU679200B2 (en) Effervescent pharmaceutical composition containing ibuprofenand method for preparing same
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
CA2303291A1 (en) Fatty acids as a diet supplement
AU5784096A (en) Method and composition for prevention of posterior capsule opacification
CA2437412A1 (en) Delayed release microtablet of b-phenylpropiophenone derivatives
CA2012257A1 (en) Anti-snoring formulations